CG
CYTK icon

Cutler Group’s Cytokinetics CYTK Stock Holding History

Cutler Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$8K Sell
10,100
-1,400
-12% -$108K ﹤0.01% 1364
2023
Q4 		$6K Buy
11,500
+5,600
+95% +$203K ﹤0.01% 2632
2023
Q3 		$30K Buy
+5,900
New +$196K ﹤0.01% 1766
2023
Q1 		– Sell
-3,200
Closed -$2K – 3943
2022
Q4 		$2K Buy
+3,200
New +$138K ﹤0.01% 3655
2022
Q3 		– Sell
-300
Closed -$1K – 5004
2022
Q2 		$1K Sell
300
-3,000
-91% -$121K ﹤0.01% 4535
2022
Q1 		$17K Buy
+3,300
New +$117K ﹤0.01% 3183
2021
Q4 		– Sell
-6,000
Closed -$10K – 5467
2021
Q3 		$10K Buy
+6,000
New +$177K ﹤0.01% 3912
2021
Q1 		– Sell
-11,400
Closed -$12K – 5737
2020
Q4 		$12K Sell
11,400
-500
-4% -$9.14K ﹤0.01% 3057
2020
Q3 		$75K Buy
+11,900
New +$278K ﹤0.01% 1507
2019
Q1 		– Sell
-8,500
Closed -$34K – 4144
2018
Q4 		$34K Buy
+8,500
New +$62.4K ﹤0.01% 1714
2018
Q2 		– Sell
-1,300
Closed -$6K – 4306
2018
Q1 		$6K Sell
1,300
-5,100
-80% -$43.7K ﹤0.01% 3144
2017
Q4 		$26K Sell
6,400
-43,100
-87% -$489K ﹤0.01% 2334
2017
Q3 		$18K Buy
49,500
+40,100
+427% +$548K ﹤0.01% 3216
2017
Q2 		$18K Buy
9,400
+6,400
+213% +$88.9K ﹤0.01% 3510
2017
Q1 		$1K Sell
3,000
-21,800
-88% -$255K ﹤0.01% 5786
2016
Q4 		$11K Buy
24,800
+6,200
+33% +$65.8K ﹤0.01% 4078
2016
Q3 		$22K Buy
+18,600
New +$194K ﹤0.01% 3320

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Cutler Group's CYTK Position: Q1 2024 in Review

Cutler Group opened a new position in Cytokinetics (CYTK) in Q1 2024: 603 shares worth $42K. The stake represents 0.01% of the portfolio and ranks #746 among its holdings. This is a return to the name: Cutler Group previously reported a position in CYTK as recently as Q3 2023.

Cutler Group first reported a position in CYTK in Q4 2015 and has held it in 22 quarters since. The position peaked at $526K in Q4 2016. 390 funds tracked by Wall St. Rank hold CYTK as of Q1 2024.

  • Cutler Group held 603 shares of Cytokinetics worth $42K as of Q1 2024.
  • Cytokinetics was a new Cutler Group position in Q1 2024.
  • Cytokinetics made up 0.01% of Cutler Group's portfolio in Q1 2024, its #746 holding.
  • Cutler Group first reported a position in Cytokinetics in Q4 2015 and has held it in 22 quarters since.
  • Cutler Group's Cytokinetics position peaked at $526K in Q4 2016.
  • 390 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.